Klinisch orientierter Schwerpunkt
FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz
Rule, S.; Jurczak, W.; Jerkeman, M. et al.
Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY studyLEUKEMIA. Bd. 32. H. 8. 2018 S. 1799-1803
Plaumann, Julian; Engelhardt, Melanie; Awwad, Mohamed H. S. et al.
IL-10 inducible CD8(+) regulatory T-cells are enriched in patients with multiple myeloma and impact the generation of antigen-specific T-cellsCANCER IMMUNOLOGY IMMUNOTHERAPY. Bd. 67. H. 11. 2018 S. 1695-1707
Qin, S.; Cheng, A-L.; Ducreux, M. P. et al.
IMbrave150: A randomised phase III study of atezolizumab 1 bevacizumab vs sorafenib in locally advanced or metastatic hepatocellular carcinomaANNALS OF ONCOLOGY. Bd. 29. 2018
Finn, Richard S.; Ducreux, Michel; Qin, Shukui et al.
IMbrave150: A randomized phase III study of 1L atezolizumab plus bevacizumab vs sorafenib in locally advanced or metastatic hepatocellular carcinoma.JOURNAL OF CLINICAL ONCOLOGY. Bd. 36. H. 15. 2018
Almstedt, K; Schmidt, M
Immuno-oncology in breast cancer – from diagnosis to therapychirurgische praxis. Bd. 83. 2018 S. 674-680
Moehler, M.
Immuno-Oncology in gastric cancer: Soon standard? If so, for whom and when?ONCOLOGY RESEARCH AND TREATMENT. Bd. 41. 2018 S. 268-268
Stein, Alexander; Moehler, Markus; Trojan, Joerg et al.
Immuno-oncology in GI tumours: Clinical evidence and emerging trials of PD-1/PD-L1 antagonistsCRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. Bd. 130. 2018 S. 13-26
Almstedt, K; Schmidt, M
Immunonkologie beim Mammakarzinom - von der Diagnose bis zur Therapiegyne. Bd. 39. 2018 S. 20-24
Moehler, Markus
Immunotherapy in Gastrointestinal Carcinoma - How to Separate Hope from HypeONCOLOGY RESEARCH AND TREATMENT. Bd. 41. H. 5. 2018 S. 264-265
Alsina, Maria; Moehler, Markus; Lorenzen, Sylvie
Immunotherapy of Esophageal Cancer: Current Status, Many Trials and Innovative StrategiesONCOLOGY RESEARCH AND TREATMENT. Bd. 41. H. 5. 2018 S. 266-271